Medpace (MEDP)
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
$591.29-0.35%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
QuarterlyIQ Insights · MEDP
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||
| Revenues | 2,782.3 | 2,530.2 | 2,109.1 | 1,885.8 | 1,460.0 | 1,142.4 | 925.9 | 861.0 | 704.6 | 436.2 | 421.6 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 436.2 | 421.6 |
| Operating Expenses & Income | |||||||||||
| Selling, General & Admin | 189.0 | 197.6 | 180.2 | 161.4 | 131.4 | 108.4 | 92.2 | 95.2 | 75.7 | 63.4 | 61.5 |
| Operating Income | 583.4 | 534.9 | 446.9 | 336.8 | 278.7 | 198.6 | 167.0 | 127.3 | 101.0 | 64.9 | 52.5 |
| Earnings from Continuing Operations | |||||||||||
| Other Non-Operating Income / Expenses | 15.5 | 7.4 | 29.1 | (1.1) | 4.2 | 3.2 | 1.5 | (2.4) | (7.1) | (7.9) | (30.5) |
| EBT, Incl. Unusual Items | 598.9 | 542.4 | 475.9 | 335.7 | 282.9 | 201.9 | 168.5 | 124.8 | 94.0 | 56.9 | 22.0 |
| Income Tax Expense | 107.4 | 91.3 | 71.5 | 52.9 | 37.5 | 20.0 | 23.1 | 24.4 | 20.8 | 17.8 | 8.5 |
| Net Income | |||||||||||
| Net Income | 491.5 | 451.1 | 404.4 | 282.8 | 245.4 | 181.8 | 145.4 | 100.4 | 73.2 | 39.1 | 13.4 |
| Per Share | |||||||||||
| Basic EPS | 17.45 | 15.64 | 13.06 | 9.20 | 7.57 | 5.06 | 4.07 | 2.79 | 2.05 | 1.00 | 0.38 |
| Diluted EPS | 17.21 | 15.28 | 12.63 | 8.88 | 7.28 | 4.81 | 3.84 | 2.67 | 1.97 | 0.98 | 0.37 |
| Revenue per Share | 97.44 | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 28.2 | 28.8 | 31.0 | 30.7 | 32.4 | 35.9 | 35.6 | 35.9 | 35.5 | 39.1 | 35.7 |
| Diluted Weighted Avg Shares | 28.6 | 29.5 | 32.0 | 31.8 | 33.7 | 37.7 | 37.7 | 37.6 | 36.9 | 39.8 | 36.3 |
| Supplemental | |||||||||||
| EBIT | 583.4 | 534.9 | 446.9 | 336.8 | 278.7 | 198.6 | 167.0 | 127.3 | 101.0 | 64.9 | 52.5 |
| Effective Tax Rate | 17.9% | — | — | 15.8% | 13.3% | 9.9% | 13.7% | 19.5% | 22.1% | 31.3% | 38.9% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.